The Roles of Endoscopy in Endometrial Cancer  by Lee, Chyi-Long et al.
Taiwan J Obstet Gynecol • December 2008 • Vol 47 • No 4 379
■ REVIEW ARTICLE ■
Introduction
Endometrial cancer is one of the most common female
malignancies in the United States, and has increased in
incidence in Taiwan in recent decades. The annual inci-
dence rates are 23.7 per 100,000 and 5.31 per 100,000,
respectively. The standard management of endome-
trial cancer involves a staging laparotomy with total
hysterectomy and bilateral salpingo-oophorectomy,
combined with pelvic and/or para-aortic lymph node
dissection. The benefits of complete surgical treatment
include not only a reduction in mortality and recurrence
rate, but also improvements in the patients’ qualities
of life. With advances in minimally invasive techniques,
endoscopy has been increasingly applied for the diag-
nosis and treatment of endometrial cancer.
Although many studies have shown promising results
regarding the use of endoscopy in the management of
endometrial cancer, some concerns still exist and merit
further discussion and investigation. These issues include
the efficacy of hysteroscopy as a diagnostic tool com-
pared with fractional dilatation and curettage (D&C),
the potential risk of retrograde dissemination of can-
cer cells by the distension media, and the feasibility of
laparoscopy for the standard staging operation. This
review discusses evidence from the literature regarding
these issues in endoscopy used in the management of
endometrial cancer.
Hysteroscopy is Superior to Fractional
D&C in Revealing Lesions in 
Endometrial Cancer
Gynecologists usually use ultrasonography and frac-
tional D&C as diagnostic tools to detect endometrial
lesions. However, ultrasonographic examination is not
reliable, and false-negative results for endometrial can-
cer are not uncommon. D&C relies on blind sampling
of endometrial specimens and has recently been found
to be unreliable for detecting early or persistent carci-
nomas following conservative treatment. Clark et al
[1] found that hysteroscopy is highly accurate and
useful in diagnosing, rather than excluding, endome-
trial cancer in women with abnormal uterine bleeding.
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A recent study performed by Bedner et al [2] com-
pared the effectiveness of D&C with hysteroscopy and
guided biopsy in perimenopausal women at risk of
endometrial hyperplasia or cancer. They found that
hysteroscopy with directed biopsy was more sensitive
than D&C for detecting all types of uterine lesions. Out
of a total of 734 patients, hysteroscopy failed to diag-
nose just four cases of endometrial pathology, com-
pared with 21 cases undiagnosed by D&C. They also
found that curettage performed after hysteroscopy
and directed biopsy did not improve the detection rate
of endometrial cancer.
The Effect of Retrograde Dissemination
of Cancer Cells in Hysteroscopy
In a prospective randomized study, Nagele et al [3]
compared normal saline and carbon dioxide as disten-
sion media in 30 patients undergoing hysteroscopy
and laparoscopy for infertility. Endometrial cells were
present in the peritoneal fluid in 6.7% of patients before
hysteroscopy and in 25% after hysteroscopy, including
23.3% of patients using normal saline and 26.7% using
carbon dioxide. These data suggest that malignant
endometrial cells were introduced into the peritoneal
cavity during hysteroscopy regardless of the use of nor-
mal saline or carbon dioxide as the distension medium.
Obermair et al [4] performed a retrospective cohort
analysis of 113 patients who underwent staging lapa-
rotomy and compared groups who underwent D&C
with or without prior diagnostic fluid hysteroscopy.
Compared with D&C alone (2.6% [1/39]), patients
undergoing D&C with diagnostic fluid hysteroscopy had
significantly higher positive or suspicious peritoneal
cytology (12.2% [9/74]; p=0.046). No differences in
myometrial invasion, histologic subtype or grade were
noted. Zerbe et al [5] found similar results.
Kadar et al [6], however, found that positive peri-
toneal cytology was not an adverse factor in endo-
metrial carcinoma, unless there was other evidence of
extrauterine disease. They studied 269 clinical stage I
and II endometrial cancer patients, 34 (12.6%) of whom
had positive peritoneal cytology. The 5-year survival rate
in patients with disease confined to the uterus was 73%
and that in patients with extrauterine disease was 13%
(p<0.001). Leveque et al [7] studied 19 patients with
stage I endometrial cancer who underwent preopera-
tive hysteroscopy. Seven (36.8%) of these patients had
positive peritoneal washings at hysterectomy, but did
not experience peritoneal recurrences. These studies
showed that retrograde seeding of indolent cancer cells
did not adversely influence prognosis.
Prospective Use of Hysteroscopy in the
Diagnosis of Endometrial Cancer
Office hysteroscopy is an under-utilized technique. 
In a recent review, Isaacson [8] pointed out that, in
comparison to nearly 100% of urologists who utilized
office cystoscopy to evaluate bladder pathology, less
than 20% of gynecologists utilized office hysteroscopy
to evaluate intrauterine pathology. As a result, many
women who could have benefited from the use of 
this technique were referred for more invasive and 
less useful procedures involving surgery and general
anesthesia.
Gynecologists should, therefore, be encouraged to
use hysteroscopy. Patients with suspected endometrial
hyperplasia and scheduled for curettage should first
undergo a hysteroscopy-directed endometrial biopsy
or resection. The current indications for hysteroscopic
diagnosis of patients with strongly suspected endo-
metrial cancer include: (1) patients presenting with
abnormal uterine bleeding and thickened endometrium;
(2) patients needing a target biopsy to differentiate
between atypical endometrial hyperplasia and cancer;
and (3) for follow-up of patients with endometrial
cancer receiving fertility-preserving treatment. Other
prospective uses of hysteroscopy in the diagnosis and
treatment of uterine cancer include: (1) in the differen-
tiation between endometrial and cervical adenocar-
cinomas; (2) for verification of cervical extension of
endometrial cancer if tumor fragments are seen in endo-
cervical curettages; and (3) during fertility-preserving
treatment of endometrial cancer.
Feasibility of Laparoscopic Staging of
Endometrial Cancer
The Cancer Committee of the International Federation
of Gynecology and Obstetrics have changed their stag-
ing classification from clinical- to surgicopathologic-
based criteria. Adjuvant treatment recommendations
are clearly influenced by information obtained from
surgical staging. Traditional abdominal surgical stag-
ing is preferable to the vaginal approach, because the
gynecologist can thoroughly assess the peritoneal cav-
ity, obtain washings for cytology, guarantee removal of
the adnexa, and sample the pelvic and para-aortic lymph
nodes.
However, with advances in minimally invasive tech-
niques, the laparoscopic-vaginal approach becomes
more effective than the conventional transabdominal
approach. There are some limitations associated with
laparoscopic surgery, such as patient obesity, difficulty
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of exposure in advanced cases, the inability to palpate
tissues, and the possibility of rupture of cysts or lymph
node capsules. However, laparoscopy has many advan-
tages, including less tissue reaction, complete removal
of blood clots and debris, and meticulous hemostasis,
all of which lead to reduced postoperative pain follow-
ing laparoscopy. Potential surgical complications, such
as infection, hemorrhage and postoperative adhesions,
may also be reduced with laparoscopy.
In a prospective randomized study comparing a
laparoscopic-vaginal approach and the conventional
abdominal approach for the treatment of patients
with endometrial cancer, the yield of pelvic and para-
aortic lymph nodes, duration of surgery, and incidence
of postoperative complications were similar in both
groups [9]. Another similar prospective study found
that the majority of patients could be treated by lap-
aroscopy with excellent surgical outcomes, shorter 
hospitalization, earlier recovery and improved quality
of life, but at a higher financial cost. They concluded 
that laparoscopy was a suitable primary modality for
the treatment of endometrial cancer [10]. Another
recent study confirmed that fewer complications and
shorter hospital stays were observed in the laparos-
copy group, compared with the conventional treat-
ment group [11].
Cancer cell dissemination caused by the uterine ma-
nipulator during laparoscopic hysterectomy is an issue
of concern. A prospective study collected two sets of
peritoneal washings, i.e. one before and one after the
insertion of the Pelosi uterine manipulator. They found
no difference between the two sets of washings in all
patients (100%; p<0.001); no patients with negative
washings before insertion of the manipulator had pos-
itive washings after the insertion [12]. However, one
recent study noted four cases of recurrence in the vagi-
nal stump in laparoscopically-treated patients, and the
authors suggested that efforts should be made during
laparoscopic procedures to minimize the risk of vagi-
nal recurrence [11]. Wang et al [13] suggested using 
a 1-0 Vicryl to close the cervix as the first step during
laparoscopy, to prevent cancer cell contamination of
the vaginal wall. They also suggested avoiding manipu-
lator use while performing laparoscopic surgery for
endometrial cancer, in order to minimize the risk of rapid
vaginal cuff recurrence.
Feasibility of Laparoscopy in Obese
Patients with Endometrial Cancer
The feasibility and safety of the use of laparoscopy in
obese women with endometrial cancer is another issue
of concern. Associated issues, such as the operation
costs, hospital stay, patient recall of postoperative
pain control, time to return to full activity and to
work, may need to be considered. Eltabbakh et al [14]
conducted a prospective study of laparoscopic surgery
in all women with clinical stage I endometrial cancer
and body mass indices between 28.0 and 60.0.
Patients with similar characteristics who underwent
laparotomy were included as a control. Laparoscopic
surgery was successful in 88.1% of obese women, with
an open conversion rate at 7.5% of patients. For the
proportion of women who underwent lymphadenec-
tomy, the incidence of complications, total cost,
patient recall of postoperative pain, and patient satis-
faction with management were all similar in both
groups. However, laparoscopy was associated with a
significantly longer operative time (194.8 vs. 137.7
minutes; p<0.001), more pelvic lymph nodes removed
(11.3 vs. 5.3; p<0.001), a smaller drop in postopera-
tive hematocrit (3.9 vs. 5.4; p=0.029), less pain med-
ication (32.3 vs. 124.1 mg; p<0.001), and a shorter
hospital stay (2.5 vs. 5.6 days; p<0.001). There was
also a trend towards earlier resumption of full activity
(23.2 vs. 45.0 days; p=0.073) and return to work
(35.3 vs. 67.0 days; p=0.055) among women who
underwent laparoscopy. They concluded that laparos-
copy was safe and feasible in most obese women with
early stage endometrial cancer, and produced better
outcomes than laparotomy. Operative endoscopy may,
therefore, play an important role in treating patients
with endometrial cancer.
Survival Following Laparoscopic Staging
Surgery for Endometrial Cancer
Many studies have found similar recurrence and sur-
vival rates in patients treated by laparoscopy and lapa-
rotomy [9,11,15–22]. These studies reported some
disadvantages of the laparoscopic approach, including
prolonged operating time, increased blood loss, and
increased cost during the learning period. However,
trends suggest that laparoscopy will play an important
role in the management of endometrial cancer in the
near future [23].
Cho et al [11] reported on 10 years’ experience of
laparoscopic management of early uterine cancer in
Korea, compared with patients treated by laparotomy.
They found no significant differences between the two
groups in terms of progression-free or overall survival,
and they, therefore, concluded that laparoscopy was 
a valid alternative to conventional laparotomy, and
does not worsen the prognosis of patients with early
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endometrial carcinoma. Another retrospective review
of women presenting with clinical stage I endometrial
carcinomas found that women who underwent laparo-
scopy and those who underwent laparotomy had simi-
lar 2-year and 5-year estimated recurrence-free survival
rates (93% vs. 94% and 90% vs. 92%, respectively), as well
as similar 2-year and 5-year overall survival rates (98% vs.
96% and 92% vs. 92%, respectively). There was no appar-
ent difference with regard to the sites of recurrence
between the groups [18].
Kalogiannidis et al [22], in a prospective cohort
study of 169 consecutive patients, reported that the
recurrence rate in the laparoscopically assisted vaginal
hysterectomy (LAVH) group was 8.7%, compared with
16% in the laparotomy group (not significant). The
actuarial overall and disease-free survival rates in the
LAVH group were 93% and 91%, respectively, compared
with 86% and 84% in the total abdominal hysterec-
tomy group (not significant).
Some studies further analyzed the risk factors for
recurrence using univariate and multivariate analyses.
One study found that surgical stage, tumor grade and
histology (but not the surgical approach) had signifi-
cant effects on survival [18], while another study
found that histologic subtype was the only independ-
ent prognostic factor for disease-free survival, and that
surgical technique again had no effect [22].
Conclusion
Advancements in technology have increased the avail-
ability of valuable minimally invasive techniques for
gynecologists to use in the management of patients
with endometrial cancer. Hysteroscopy is indispens-
able for the initial diagnosis and early detection of
occult tumors or tumor recurrence. Although hys-
teroscopy could facilitate tumor cell dissemination
into the pelvic cavity, retrograde seeding of indolent
cancer cells does not appear to adversely influence prog-
nosis. Laparoscopy plays an important role in treating
endometrial cancer. It offers many advantages, includ-
ing avoidance of an abdominal incision, a shorter hos-
pital stay, and probably a more rapid recovery time.
Moreover, metastatic disease can be detected laparo-
scopically. Most studies failed to show any difference
in recurrence rates or survival between patients treated
by laparoscopic or abdominal staging surgery. Lap-
aroscopy could be performed in obese patients and
resulted in better operation outcomes than laparotomy.
A laparoscopic approach is, therefore, a feasible alter-
native to the conventional treatment of endometrial
cancer.
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